Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,900 | -2,430 | -1,640 | -960 | -2,730 |
| Depreciation Amortization | 60 | 20 | 9 | 4 | 50 |
| Other Working Capital | 210 | 490 | 370 | 470 | -240 |
| Other Operating Activity | 160 | 120 | 91 | 66 | 250 |
| Operating Cash Flow | $-2,470 | $-1,800 | $-1,170 | $-420 | $-2,670 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -130 | 0 | 0 | 0 | -7 |
| Other Investing Activity | -30 | -20 | -10 | 0 | 187 |
| Investing Cash Flow | $-160 | $-20 | $-10 | $0 | $180 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 2,100 | 990 | 190 | 170 | 1,330 |
| Financing Cash Flow | $2,100 | $990 | $190 | $170 | $1,330 |
| Beginning Cash Position | 1,590 | 1,590 | 1,590 | 1,590 | 2,740 |
| End Cash Position | 1,050 | 750 | 590 | 1,340 | 1,590 |
| Net Cash Flow | $-530 | $-830 | $-1,000 | $-240 | $-1,150 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,470 | -1,800 | -1,170 | -420 | -2,670 |
| Free Cash Flow | -2,470 | -1,800 | -1,170 | -420 | -2,670 |